Epsilon M&A Deal Report - Abcodia
Transaction Multiples for the Valuation of Private Companies
GENinCode / Abcodia
No EMAT :
116272
Announced Date :
26/09/2022
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
GENinCode
Target :
Abcodia
Country :
United Kingdom
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Abcodia is a biotechnology company that focuses on the discovery and validation of biomarkers for cancer screening in genetically high-risk populations. > Clinical stage company engaged in the...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | ns | ns | ||||||
| Current |
Rating :
**
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 50
| Date | Acquirer | Target | Country | Multiples | See details |
| 03/04/2023 | Sonic Healthcare | Diagnosticum MVZ Diagnosticum | Germany | ** | 116268 |
| 21/07/2022 | Spineway | Spine Innovations | Rhône | ** | 116254 |
Source: Epsilon Research / EMAT
